Special series: Dr. Rai and Dr. Kamphuis talk about preparing and keeping your CV updated
In 'Episode 2' of the series on "What young urologists need to know," segment 1 covers the topic of "Navigating the transition from residency to professional urology practice." Dr. Bhavan Prasad Rai (...
2 Joulu 202310min
Special series: Ms. Moreno-Fontela and Assoc. Prof. Kasivisvanathan discuss the significant transition after residency
In 'Episode 1' of the series on "What young urologists need to know," segment 1 covers the topic of "Navigating the transition from residency to professional urology practice." Assoc. Prof. Veeru Kasi...
25 Marras 202323min
Prof. James Catto (GB) shares results of THOR-2 cohort 1 study
In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks with Prof. James Catto (GB) about the THOR-2 cohort 1 study: Results of erdafitinib (ERDA) vs intravesical chemotherapy (chemo...
12 Marras 20237min
Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg
In this podcast, Dr. Neeraj Agarwal (US), presidential endowed chair of cancer research at the Huntsman Cancer Institute, University of Utah, shares the results of the LITESPARK-013 Phase 2 trial - "S...
8 Marras 20234min
Prof. Roberto Iacovelli: Drug interruptions in mRCC IO-TKI (Avelumab and axitinib) is safe and may reduce toxicity and cost for the treatment
In this podcast, UROONCO RCC associate editor Dr. Teele Kuusk (GB) talks with Prof. Roberto Iacovelli (IT), Gostino Gemelli University Polyclinic, Rome, about the abstract he presented at ESMO 2023, "...
1 Marras 20236min
Prof. Albiges shares LITESPARK-005 study results: Belzutifan improves PFS in pretreated mRCC patients
In this podcast, UROONCO RCC associate editor Dr. Teele Kuusk (GB) talks with medical oncologist Prof. Laurence Albiges (FR), Head of the Department of Oncology at Gustave Roussy, about her abstract: ...
28 Loka 20235min
ESMO 2023 special: Dr. Van Der Heijden talks about the phase 3 CheckMate 901 trial results
In this podcast from ESMO 2023, UROONCO BCa associate editor Dr. Laura Mertens (NL) talks with Dr. Michiel Van Der Heijden (NL) on his abstract “Nivolumab plus gemcitabine-cisplatin versus gemcitabine...
24 Loka 20238min
ESMO 2023 special: Prof. Powles shares positive KEYNOTE-A39 trial results
In this special podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks with Prof. Thomas Powles (GB) about the positive results of the EV-302/KEYNOTE-A39 trial that were announced at ESMO 2...
22 Loka 20239min
